<DOC>
	<DOCNO>NCT01411176</DOCNO>
	<brief_summary>Patients early gastric cancer , require therapeutic upper gastrointestinal endoscopy , endoscopic mucosal resection ( EMR ) endoscopic submucosal dissection ( ESD ) , receive intragastric spray NPO-11 placebo . The superiority NPO-11 placebo anti-peristaltic agent verify randomize , double-blind , parallel-assignment design base proportion patient suppress gastric peristalsis procedure . The degree gastric peristalsis assess independent committee . The safety NPO-11 evaluate base adverse event adverse drug reaction ( ADRs ) observe administration seven day administration comparison placebo group .</brief_summary>
	<brief_title>Phase III Study NPO-11 Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>inpatient outpatient either sex require therapeutic upper gastrointestinal endoscopy ( EMR ESD ) meet criterion ( 1 ) ( 4 ) enrol study . Patients provide write informed consent voluntary participation study . The criterion ( 2 ) ( 3 ) confirm endoscopic observation start intend treatment . 1 . Patients early gastric cancer locate low third stomach , require therapeutic upper gastrointestinal endoscopy ( EMR ESD ) ( except intend treatment use scope &lt; 9 mm diameter ) 2 . Differentiated type intramucosal gastric cancer suspect lesion , â‰¤ 2 cm size , ulcer find 3 . Patients single intended lesion treatment 4 . Patients older 20 year time consent Patients meet follow criterion exclude study beforehand . The criterion ( 3 ) ( 5 ) confirm endoscopic observation start intend treatment . 1 . Patients history surgery upper gastrointestinal tract 2 . Patients require emergency endoscopy 3 . Patients severe gastric stenosis deformation make observation gastric peristalsis difficult 4 . Patients require emergency endoscopic treatment except intend lesion 5 . Patients lesion extend pyloric ring 6 . Patients ongoing cancer treatment ( chemotherapy radiotherapy ) 7 . Patients pacemaker 8 . Patients know bleeding tendency Patients difficulty antithrombogenic agent withdrawal 9 . Patients history shock hypersensitivity lmenthol peppermint oil 10 . Patients contraindication glucagon 11 . Patients contraindication benzodiazepine , pethidine hydrochloride , epinephrine 12 . Pregnant lactate woman , woman childbearing potential , woman plan become pregnant study 13 . Patients receive investigational drug within four month consent participate clinical study 14 . Patients otherwise ineligible participation study investigator 's opinion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>upper gastrointestinal endoscopy</keyword>
	<keyword>suspect gastric cancer</keyword>
</DOC>